Get your free personalized podcast brief
We scan new podcasts and send you the top 5 insights daily.
When facing a crisis like COVID, waiting for perfect data before acting is not a 'safe' option. The status quo of inaction often carries its own significant, accumulating costs—like student learning loss—that must be factored into the decision.
Related Insights
The best leaders act on incomplete information, understanding that 100% certainty is a myth that only exists in hindsight. The inability to decide amid ambiguity—choosing inaction—is a greater failure than making the wrong call.
Erik van den Berg asserts that the primary value of biotech leadership is making decisions with limited information. Because time is the most critical resource, delaying decisions is not a neutral act of caution. It actively wastes money and increases the overall cost of investment and drug development.
When faced with imperfect choices, treat the decision like a standardized test question: gather the best available information and choose the option you believe is the *most* correct, even if it's not perfect. This mindset accepts ambiguity and focuses on making the best possible choice in the moment.
In high-stakes leadership roles, the paralysis of indecision often causes more damage than a suboptimal choice. Making a poor decision allows for feedback, correction, and continued momentum, whereas inaction leads to stagnation and missed opportunities. The key is to decide, learn, and iterate quickly.
The "if one person dies, it's one too many" mentality, while sounding noble, is framed as a sign of poor leadership. Effective leaders must synthesize complex data and make decisions based on second and third-order effects, not just a single, emotionally resonant metric like zero risk.
Leaders often face analysis paralysis, striving for the perfect choice. This mindset suggests that making a suboptimal decision and adapting is superior to making no decision at all, as inaction stalls momentum and creates uncertainty for the team.
Entrepreneurship is defined by making decisions with incomplete information. Most choices should be directional, reasoned from first principles. Only irreversible, "one-way door" decisions justify delaying action for more data collection, as you will never have complete data.
Policymakers confront an 'evidence dilemma': act early on potential AI harms with incomplete data, risking ineffective policy, or wait for conclusive evidence, leaving society vulnerable. This tension highlights the difficulty of governing rapidly advancing technology where impacts lag behind capabilities.
Agency leaders often delay decisions for fear of being wrong, creating significant opportunity costs and mental distraction. This paralysis is more damaging than the risk of an incorrect choice. Any decision is better than indecision because it provides momentum and learning, a lesson especially critical for small or solo-led agencies.
In extreme uncertainty like a fire or nuclear incident, waiting for perfect information is impossible. Effective leaders take small, iterative actions to gather data and update their strategy in real-time. This approach of 'acting your way into knowing' is more effective than trying to know everything before acting.
